Zhejiang Jingxin Pharmaceutical Dividends and Buybacks
Dividend criteria checks 6/6
Zhejiang Jingxin Pharmaceutical is a dividend paying company with a current yield of 2.44% that is well covered by earnings.
Key information
2.4%
Dividend yield
-0.004%
Buyback Yield
| Total Shareholder Yield | 2.4% |
| Future Dividend Yield | 3.1% |
| Dividend Growth | 12.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.300 |
| Payout ratio | 36% |
Recent dividend and buyback updates
Recent updates
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt
Oct 04
Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (SZSE:002020) Low P/E No Reason For Excitement
Sep 12Zhejiang Jingxin Pharmaceutical (SZSE:002020) Has Announced A Dividend Of CN¥0.30
May 21Zhejiang Jingxin Pharmaceutical's (SZSE:002020) Problems Go Beyond Weak Profit
Apr 08We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt
Mar 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 002020's dividends per share have been stable in the past 10 years.
Growing Dividend: 002020's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Zhejiang Jingxin Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (002020) | 2.4% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Pharmaceuticals) | 1.7% |
| Analyst forecast (002020) (up to 3 years) | 3.1% |
Notable Dividend: 002020's dividend (2.44%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 002020's dividend (2.44%) is in the top 25% of dividend payers in the CN market (2.17%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (35.7%), 002020's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (39.9%), 002020's dividend payments are well covered by cash flows.